Skip to content

Vanda Pharmaceuticals Inc Sustainability Reports

Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs. Its product portfolio includes commercialized treatments for schizophrenia, bipolar I disorder, and sleep disorders.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900AY8VOOQBKJ0O70

FIGI: BBG001SP95N5

12 reports from 2006 to 2023